IndexIQ Advisors
ACHN

IndexIQ Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

IndexIQ Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-448,355
Closed -$2.7M – 1187
2019
Q4 		$2.7M Buy
+448,355
New +$2.6M 0.1% 157

IndexIQ Advisors's ACHN Position: Q1 2020 in Review

IndexIQ Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 448,355 shares — an estimated $2.7M sold.

IndexIQ Advisors first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $2.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • IndexIQ Advisors reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • IndexIQ Advisors sold 448,355 Achillion Pharmaceuticals shares in Q1 2020, an estimated $2.7M.
  • IndexIQ Advisors first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • IndexIQ Advisors's Achillion Pharmaceuticals position peaked at $2.7M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on IndexIQ Advisors's 13F filing for Q1 2020, filed 8 May 2020.